Stay updated on Sitravatinib Combo Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo Clinical Trial page.

Latest updates to the Sitravatinib Combo Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov record for the sitravatinib rollover study is now displayed, with its study design, participant criteria, trial locations, and safety outcomes. It also includes the completed study’s record dates, documents, and links to sponsor information.SummaryDifference54%

- Check12 days agoChange DetectedThe site footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA sitewide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2; the study record remains unavailable on this page.SummaryDifference1%

- Check40 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.1 instead of v3.7.0. The page continues to display a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record. Consequently, the study details and related sections are no longer visible and are replaced by the error page content.SummaryDifference18%

- Check61 days agoChange DetectedThe page's revision tag was updated to v3.7.0, replacing the previous v3.6.6 and indicating an updated version of the study documentation.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo Clinical Trial page.